Anti-fibrotic activity of

Euglena NASH Paramylon fibrosis microalgae

Journal

Food science & nutrition
ISSN: 2048-7177
Titre abrégé: Food Sci Nutr
Pays: United States
ID NLM: 101605473

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 08 05 2018
revised: 10 09 2018
accepted: 13 09 2018
entrez: 26 1 2019
pubmed: 27 1 2019
medline: 27 1 2019
Statut: epublish

Résumé

Progression to non-alcoholic steatohepatitis (NASH) manifests as hepatitis, fibrosis, and sometimes carcinoma, resulting in liver failure. Various clinical trials have indicated that several pharmacological agents, including angiotensin II receptor blockers (ARBs) or farnesoid X receptor (FXR) agonists, are effective in NASH treatment. In addition, functional foods are expected to be important alternatives for treating or preventing NASH. Recently, focus has been directed toward microalgae as dietary supplements, mainly for lifestyle-related diseases, because they contain various nutrients and functional ingredients. Specifically, a unicellular microalga

Identifiants

pubmed: 30680167
doi: 10.1002/fsn3.828
pii: FSN3828
pmc: PMC6341149
doi:

Types de publication

Journal Article

Langues

eng

Pagination

139-147

Références

FEBS Lett. 2018 Dec;592(24):4020-4027
pubmed: 30328102
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
Front Microbiol. 2016 Feb 10;7:129
pubmed: 26904005
Gastroenterology. 1998 Apr;114(4):842-5
pubmed: 9547102
Diabetes Care. 2012 Apr;35(4):873-8
pubmed: 22374640
J Vet Med Sci. 2009 Jul;71(7):885-90
pubmed: 19652474
Hepatology. 2011 Dec;54(6):2185-97
pubmed: 21826694
Hepatology. 2017 Jan;65(1):350-362
pubmed: 27358174
Dig Dis Sci. 2007 Dec;52(12):3455-64
pubmed: 17410441
World J Gastroenterol. 2007 Sep 14;13(34):4539-50
pubmed: 17729403
Mol Metab. 2016 Jun 14;5(9):782-94
pubmed: 27617201
Foods. 2016 Nov 29;5(4):
pubmed: 28231175
Semin Liver Dis. 2015 Aug;35(3):221-35
pubmed: 26378640
Food Funct. 2016 Nov 9;7(11):4655-4659
pubmed: 27775129
Gastroenterology. 2008 May;134(6):1655-69
pubmed: 18471545
Int J Endocrinol. 2013;2013:587140
pubmed: 23997767
J Vet Med Sci. 2010 Jun;72(6):755-63
pubmed: 20160419
Nat Rev Gastroenterol Hepatol. 2011 Jan;8(1):35-44
pubmed: 21119613
J Hepatol. 2010 Jun;52(6):913-20
pubmed: 20413174
Sci Rep. 2015 Aug 20;5:12466
pubmed: 26289793
Food Sci Nutr. 2018 Nov 08;7(1):139-147
pubmed: 30680167
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Hepatology. 2012 Jun;55(6):2005-23
pubmed: 22488764
BMC Res Notes. 2009 May 05;2:70
pubmed: 19416517
Dig Dis. 2010;28(1):162-8
pubmed: 20460906
Food Funct. 2013 Nov;4(11):1685-90
pubmed: 24104447
Med Mol Morphol. 2013 Sep;46(3):141-52
pubmed: 23430399

Auteurs

Ayaka Nakashima (A)

euglena Co., Ltd. Tokyo Japan.

Ryota Sugimoto (R)

euglena Co., Ltd. Tokyo Japan.

Kengo Suzuki (K)

euglena Co., Ltd. Tokyo Japan.

Yuka Shirakata (Y)

SMC Laboratories, Inc. Tokyo Japan.

Taishi Hashiguchi (T)

SMC Laboratories, Inc. Tokyo Japan.

Chikara Yoshida (C)

SMC Laboratories, Inc. Tokyo Japan.

Yoshihisa Nakano (Y)

Center for Research and Development of Bioresources Osaka Prefecture University Osaka Japan.

Classifications MeSH